BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36245230)

  • 21. Concordance of folate receptor-α expression between biopsy, primary tumor and metastasis in breast cancer and lung cancer patients.
    Boogerd LS; Boonstra MC; Beck AJ; Charehbili A; Hoogstins CE; Prevoo HA; Singhal S; Low PS; van de Velde CJ; Vahrmeijer AL
    Oncotarget; 2016 Apr; 7(14):17442-54. PubMed ID: 26943581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes.
    Bax HJ; Chauhan J; Stavraka C; Santaolalla A; Osborn G; Khiabany A; Grandits M; López-Abente J; Palhares LCGF; Chan Wah Hak C; Robinson A; Pope A; Woodman N; Naceur-Lombardelli C; Malas S; Coumbe JEM; Nakamura M; Laddach R; Mele S; Crescioli S; Black AM; Lombardi S; Canevari S; Figini M; Sayasneh A; Tsoka S; FitzGerald K; Gillett C; Pinder S; Van Hemelrijck M; Kristeleit R; Ghosh S; Montes A; Spicer J; Karagiannis SN; Josephs DH
    Br J Cancer; 2023 Jan; 128(2):342-353. PubMed ID: 36402875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folate receptor α is associated with poor clinicopathological perspectives in breast carcinoma.
    Aboulhagag NAE; Torky RF; Fadel SA
    Pathophysiology; 2018 Mar; 25(1):71-76. PubMed ID: 29395794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression of folate receptor alpha in ovarian epithelial tumors].
    Shen DH; Xie JL; Zhang YL; Wang Y
    Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):747-51. PubMed ID: 21215165
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Altwerger G; Bonazzoli E; Bellone S; Egawa-Takata T; Menderes G; Pettinella F; Bianchi A; Riccio F; Feinberg J; Zammataro L; Han C; Yadav G; Dugan K; Morneault A; Ponte JF; Buza N; Hui P; Wong S; Litkouhi B; Ratner E; Silasi DA; Huang GS; Azodi M; Schwartz PE; Santin AD
    Mol Cancer Ther; 2018 May; 17(5):1003-1011. PubMed ID: 29440294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases.
    Ferns DM; Heeren AM; Samuels S; Bleeker MCG; de Gruijl TD; Kenter GG; Jordanova ES
    J Immunother Cancer; 2016; 4():78. PubMed ID: 27895918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IMGN853, a Folate Receptor-α (FRα)-Targeting Antibody-Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FRα-Expressing Tumors.
    Ab O; Whiteman KR; Bartle LM; Sun X; Singh R; Tavares D; LaBelle A; Payne G; Lutz RJ; Pinkas J; Goldmacher VS; Chittenden T; Lambert JM
    Mol Cancer Ther; 2015 Jul; 14(7):1605-13. PubMed ID: 25904506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of the number of the metastatic lymph nodes in locally early-stage cervical cancer: squamous cell carcinoma versus non-squamous cell carcinoma.
    Aslan K; Haberal A; Akıllı H; Meydanli MM; Ayhan A
    Arch Gynecol Obstet; 2021 Nov; 304(5):1279-1289. PubMed ID: 33772630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NQO1 overexpression is associated with poor prognosis in squamous cell carcinoma of the uterine cervix.
    Ma Y; Kong J; Yan G; Ren X; Jin D; Jin T; Lin L; Lin Z
    BMC Cancer; 2014 Jun; 14():414. PubMed ID: 24912939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined use of EpCAM and FRα enables the high-efficiency capture of circulating tumor cells in non-small cell lung cancer.
    Chen L; Peng M; Li N; Song Q; Yao Y; Xu B; Liu H; Ruan P
    Sci Rep; 2018 Jan; 8(1):1188. PubMed ID: 29352248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial.
    Zamarin D; Walderich S; Holland A; Zhou Q; Iasonos AE; Torrisi JM; Merghoub T; Chesebrough LF; Mcdonnell AS; Gallagher JM; Li Y; Hollmann TJ; Grisham RN; Erskine CL; Block MS; Knutson KL; O'Cearbhaill RE; Aghajanian C; Konner JA
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32503949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fischer 344 Rat: A Preclinical Model for Epithelial Ovarian Cancer Folate-Targeted Therapy.
    Azaïs H; Queniat G; Bonner C; Kerdraon O; Tardivel M; Jetpisbayeva G; Frochot C; Betrouni N; Collinet P; Mordon S
    Int J Gynecol Cancer; 2015 Sep; 25(7):1194-200. PubMed ID: 26244757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detecting Functional and Accessible Folate Receptor Expression in Cancer and Polycystic Kidneys.
    Chu H; Shillingford JM; Reddy JA; Westrick E; Nelson M; Wang EZ; Parker N; Felten AE; Vaughn JF; Xu LC; Lu YJ; Vlahov IR; Leamon CP
    Mol Pharm; 2019 Sep; 16(9):3985-3995. PubMed ID: 31356752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folate receptor α expression and significance in endometrioid endometrium carcinoma and endometrial hyperplasia.
    Senol S; Ceyran AB; Aydin A; Zemheri E; Ozkanli S; Kösemetin D; Sehitoglu I; Akalin I
    Int J Clin Exp Pathol; 2015; 8(5):5633-41. PubMed ID: 26191275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A T-cell engaging bispecific antibody with a tumor-selective bivalent folate receptor alpha binding arm for the treatment of ovarian cancer.
    Avanzino BC; Prabhakar K; Dalvi P; Hartstein S; Kehm H; Balasubramani A; Boudreau AA; Buelow B; Chang K; Davison LM; Iyer S; Kalwit V; Lewis Wilson K; Malik-Chaudhry HK; Pierson W; Pineda G; Rangaswamy US; Saiganesh S; Schellenberger U; Ugamraj HS; Yabut RD; Buelow R; Chapman J; Trinklein ND; Harris KE
    Oncoimmunology; 2022; 11(1):2113697. PubMed ID: 36016696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Folate-appended cyclodextrin carrier targets ovarian cancer cells expressing the proton-coupled folate transporter.
    Saito S; Koya Y; Kajiyama H; Yamashita M; Kikkawa F; Nawa A
    Cancer Sci; 2020 May; 111(5):1794-1804. PubMed ID: 32154964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of folate receptor alpha in cancer development, progression and treatment: cause, consequence or innocent bystander?
    Kelemen LE
    Int J Cancer; 2006 Jul; 119(2):243-50. PubMed ID: 16453285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream(®) for Detecting (or Monitoring) the Expression of Folate Receptor Alpha.
    O'Shannessy DJ; Davis DW; Anderes K; Somers EB
    Biomark Insights; 2016; 11():7-18. PubMed ID: 26848256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical significance of σ1 receptor over-expression in cervical cancer and the effect of its synthetic ligands on the growth of cervical cancer cells].
    Deng YQ; Zhou XH; Jiang LL; Tang XJ; Zhang YX; Cui JQ
    Zhonghua Fu Chan Ke Za Zhi; 2017 Jul; 52(7):473-482. PubMed ID: 28797155
    [No Abstract]   [Full Text] [Related]  

  • 40. Production of a High-affinity Monoclonal Antibody Reactive with Folate Receptors Alpha and Beta.
    Nagai T; Furusho Y; Li H; Hasui K; Matsukita S; Sueyoshi K; Yanagi M; Hatae M; Takao S; Matsuyama T
    Monoclon Antib Immunodiagn Immunother; 2015 Jun; 34(3):181-90. PubMed ID: 26090596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.